CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) Director James Mulay sold 1,964 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $60.12, for a total value of $118,075.68. Following the completion of the transaction, the director owned 654 shares in the company, […]